sparteine - CISMeF

Preferred Label : sparteine;

MeSH definition : A quinolizidine alkaloid isolated from several FABACEAE including LUPINUS; SPARTIUM; and CYTISUS. It has been used as an oxytocic and an anti-arrhythmia agent. It has also been of interest as an indicator of CYP2D6 genotype.;

MeSH synonym : sparteine, (7s-(7alpha,7aalpha,14alpha,14abeta))-isomer; l-sparteine; sparteine, (-)-Isomer; 7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-, (7S-(7alpha,7aalpha,14alpha,14abeta))-; Lupinidin; Lupinidine;

CISMeF synonym : 6160-12-9 (Sparteine sulfate);

MeSH hyponym : sparteine hydrochloride, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer; sparteine sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer; sparteine monohydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer; sparteine sulfate anhydrous; sparteine sulfate; Sparteine Sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer; sparteine hydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer; sparteine hydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer; sparteine monohydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer; sparteine, (7R-(7alpha,7abeta,14alpha,14abeta))-Isomer; depasan retard; Pachycarpine Sulfate (1:1), Pentahydrate, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer; Anhydrous, Sparteine Sulfate; Sulfate Anhydrous, Sparteine;

Related MeSH term : sparteine, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer; sparteine, (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer; sparteine, (7S-(7alpha,7abeta,14alpha,14abeta))-Isomer; Sparteine, ( )-Isomer; D-sparteine; Pachycarpine; alpha-Isosparteine; alpha Isosparteine; Genisteine Alkaloid; beta-Isosparteine; beta Isosparteine;

MeSH CAS label : 7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazocine, dodecahydro-, (7S-(7alpha,7aalpha,14alpha,14abeta))-;

MeSH Related Number : sparteine hydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer; sparteine hydrochloride, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer; sparteine hydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer; sparteine monohydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer; sparteine, (7S-(7alpha,7abeta,14alpha,14abeta))-Isomer; sparteine sulfate; sparteine sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer; sparteine sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer; sparteine, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer; sparteine, (7R-(7alpha,7abeta,14alpha,14abeta))-Isomer; sparteine, (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer; sparteine monohydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer; 14703-10-7 (unspecified HI(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer); 299-39-8 (sulfate[1:1](7S-(7alpha,7aalpha,14alpha,14abeta))-isomer); 3599-17-5 (mono-HCl(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer); 42808-46-8 (unspecified HCl(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer); 446-95-7 ((7S-(7alpha,7aalpha,14alpha,14aalpha))-isomer); 492-06-8 ((7R-(7alpha,7abeta,14alpha,14abeta))-isomer); 51799-26-9 (mono-HI(7R-(7alpha,7aalpha,14alpha,14abeta))-isomer); 52670-59-4 (sulfate[1:1](7S-(7alpha,7aalpha,14alpha,14aalpha))-isomer); 6160-12-9 (sulfate[1:1].pentahydrate((7S-(7alpha,7aalpha,14alpha,14abeta))-isomer)); 72198-25-5 (unspecified HCl(7S-(7alpha,7aalpha,14alpha,14abeta))-isomer); 90-39-1 (Sparteine); sparteine sulfate anhydrous; 24915-04-6; 3D76XVF9R0; 492-08-0; GQ3J2TLZ7E;

Registry Number MeSH : 90-39-1;

Related CAS MeSH : 42808-46-8 (Sparteine hydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer); 72198-25-5 (Sparteine hydrochloride, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer); 14703-10-7 (Sparteine hydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer); 3599-17-5 (Sparteine monohydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer); 24915-04-6 (Sparteine, (7S-(7alpha,7abeta,14alpha,14abeta))-Isomer); 52670-59-4 (Sparteine sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer); 299-39-8 (Sparteine sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer); 492-08-0 (Sparteine, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer); 492-06-8 (Sparteine, (7R-(7alpha,7abeta,14alpha,14abeta))-Isomer); 446-95-7 (Sparteine, (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer); 51799-26-9 (Sparteine monohydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer); GQ3J2TLZ7E (Sparteine sulfate); 3D76XVF9R0 (Sparteine sulfate anhydrous);

Wikipedia link : https://en.wikipedia.org/wiki/Sparteine;

Codes EINECS : 201-988-8;

Is substance : O;

UNII : 298897D62S;

InChIKey : SLRCCWJSBJZJBV-ZQDZILKHSA-N;

Details

Origin ID

D013034;

UMLS CUI

C0037760;

ATC code(s)
- sparteine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Sparteine [ICHI extension code]
- Sparteine Sulfate [NCIt concept]
- Sparteine sulfate (substance) [SNOMED CT concept]
- Sparteine sulfate anhydrous [Substance BNPC]
CISMeF manual mappings
- sparteine [Substance BNPC]
Pharmacological action(s)
- anti-arrhythmia agents [MeSH Descriptor]
- oxytocics [MeSH Descriptor]
Record concept(s)
- Sparteine Sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer [MeSH concept]
- depasan retard [MeSH concept]
- sparteine [MeSH concept]
- sparteine hydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer [MeSH concept]
- sparteine hydrochloride, (7S-(7alpha,7aalpha,14alpha,14abeta))-Isomer [MeSH concept]
- sparteine hydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer [MeSH concept]
- sparteine monohydrochloride, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer [MeSH concept]
- sparteine monohydroiodide, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer [MeSH concept]
- sparteine sulfate [MeSH concept]
- sparteine sulfate (1:1), (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer [MeSH concept]
- sparteine sulfate anhydrous [MeSH concept]
- sparteine, (7R-(7alpha,7aalpha,14alpha,14abeta))-Isomer [MeSH concept]
- sparteine, (7R-(7alpha,7abeta,14alpha,14abeta))-Isomer [MeSH concept]
- sparteine, (7S-(7alpha,7aalpha,14alpha,14aalpha))-Isomer [MeSH concept]
- sparteine, (7S-(7alpha,7abeta,14alpha,14abeta))-Isomer [MeSH concept]
Related MeSH Supplementary Concept(s)
- (sparteine-N,N')(maleonitriledithiolato-S,S')copper(II) [MeSH Supplementary Concept]
- 10,17-dioxosparteine [MeSH Supplementary Concept]
- 13-hydroxylupanine [MeSH Supplementary Concept]
- 13-hydroxylupanine-2-pyrrolecarbonic acid [MeSH Supplementary Concept]
- 17-butylsparteine [MeSH Supplementary Concept]
- 17-oxosparteine [MeSH Supplementary Concept]
- 17-pentylsparteine [MeSH Supplementary Concept]
- 2-dehydrosparteine [MeSH Supplementary Concept]
- 2-hydroxysparteine [MeSH Supplementary Concept]
- 2-thionosparteine [MeSH Supplementary Concept]
- 5,6-dehydrolupanine [MeSH Supplementary Concept]
- 5-dehydrosparteine [MeSH Supplementary Concept]
- N-methylalbine [MeSH Supplementary Concept]
- angustifoline [MeSH Supplementary Concept]
- bis(azido-kappaN)(sparteine-kappa(2)N,N')copper(II) [MeSH Supplementary Concept]
- eutergine [MeSH Supplementary Concept]
- lindenianine [MeSH Supplementary Concept]
- lupanine [MeSH Supplementary Concept]
- lupinine [MeSH Supplementary Concept]
- pulsnorma [MeSH Supplementary Concept]
- sparteine N-16-oxide [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Sparteine [ICD-11 Extension code]
- Sparteine [NCIt concept]
- Sparteine (substance) [SNOMED CT concept]
- sparteine [ATC Code]
- sparteine [Substance BNPC]
- sparteine [SNOMED Notion]
Validated automatic mappings to BTNT
- Sparteine sulfate (substance) [SNOMED CT concept]
- sparteine [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients